Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07295730 · ClinicalTrials.gov registry record · NA
3D Modalities for Medical Student Education of Congenital Heart Disease
A NA study of Tetralogy of Fallot (TOF) and Hypoplastic Left Heart Syndrome (HLHS), sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT07295730 is a NA study of Tetralogy of Fallot (TOF) and Hypoplastic Left Heart Syndrome (HLHS) that has completed, run by Case Western Reserve University. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07295730, a NA study of Tetralogy of Fallot (TOF) and Hypoplastic Left Heart Syndrome (HLHS), has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if 3D-printed heart models and augmented reality can be useful modalities to teach medical students about congenital heart disease. The main questions it aims to answer are: 1. Does using 3D-printed heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods? 2. Does using augmented reality heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods? 3. How can these modalities best be integrated into standard medical school curricula? Participants will: 1. Take a pre-test consisting of questions regarding anatomy and physiology of the normal heart as well as two congenital heart diseases. 2. Be randomized into 3 groups that receive a teaching session using either slide-based lecture, 3D-printed models, or augmented reality. 3. Take a post-test of the same questions from the pre-test. 4. Take a delayed post-test of the same questions with additional subjective questions about their experience with their assigned modality.
Conditions Studied
Interventions
- OTHER 3D-printed heart models and augmented reality
Study Locations (1)
Ohio
- Case Western Reserve University School of Medicine - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2025-11-20 |
| Est. Completion | 2025-12-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07295730
The ClinicalTrials.gov registry entry for NCT07295730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tetralogy of Fallot (TOF) appearing as the primary indexed condition, and to 1 intervention - of which 3D-printed heart models and augmented reality is the first listed.
NCT07295730 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07295730 about?
NCT07295730 is a clinical study titled "3D Modalities for Medical Student Education of Congenital Heart Disease". The goal of this clinical trial is to learn if 3D-printed heart models and augmented reality can be useful modalities to teach medical students about congenital heart disease. The main questions it aims to answer are: 1. Does using 3D-printed heart models improve learners' understanding of congenit...
What is the current status of trial NCT07295730?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2025-11-20. Estimated completion is 2025-12-09.
What conditions does trial NCT07295730 study?
This clinical trial studies the following conditions: Tetralogy of Fallot (TOF), Hypoplastic Left Heart Syndrome (HLHS).
What interventions are being tested in trial NCT07295730?
The interventions under investigation include: 3D-printed heart models and augmented reality (OTHER).
Who is sponsoring clinical trial NCT07295730?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07295730 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetralogy of Fallot (TOF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.